Similar articles for PMID: 11805334

Year	Number of Results
1994	1
1997	1
1998	1
1999	3
2000	6
2001	3
2002	10
2003	10
2004	9
2005	6
2006	4
2007	5
2008	4
2009	5
2010	2
2011	2
2012	1
2013	5
2015	4
2016	2
2018	1
2020	1
2024	0

1

Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.

Kawada T, Nakazawa M, Nakauchi S, Yamazaki K, Shimamoto R, Urabe M, Nakata J, Hemmi C, Masui F, Nakajima T, Suzuki J, Monahan J, Sato H, Masaki T, Ozawa K, Toyo-Oka T. Kawada T, et al. Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):901-6. doi: 10.1073/pnas.022641799. Proc Natl Acad Sci U S A. 2002. PMID: 11805334 Free PMC article.

2

Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy.

Kawada T, Sakamoto A, Nakazawa M, Urabe M, Masuda F, Hemmi C, Wang Y, Shin WS, Nakatsuru Y, Sato H, Ozawa K, Toyo-oka T. Kawada T, et al. Biochem Biophys Res Commun. 2001 Jun 8;284(2):431-5. doi: 10.1006/bbrc.2001.4962. Biochem Biophys Res Commun. 2001. PMID: 11394897

3

[Somatic gene therapy of dilated cardiomyopathy].

Kawada T, Nakazawa M, Toyo-Oka T. Kawada T, et al. Nihon Yakurigaku Zasshi. 2002 Jan;119(1):37-44. doi: 10.1254/fpj.119.37. Nihon Yakurigaku Zasshi. 2002. PMID: 11862755 Japanese.

4

Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.

Li J, Wang D, Qian S, Chen Z, Zhu T, Xiao X. Li J, et al. Gene Ther. 2003 Oct;10(21):1807-13. doi: 10.1038/sj.gt.3302078. Gene Ther. 2003. PMID: 12960970

5

A novel scheme of dystrophin disruption for the progression of advanced heart failure.

Kawada T, Masui F, Tezuka A, Ebisawa T, Kumagai H, Nakazawa M, Toyo-Oka T. Kawada T, et al. Biochim Biophys Acta. 2005 Aug 1;1751(1):73-81. doi: 10.1016/j.bbapap.2005.01.001. Epub 2005 Jan 26. Biochim Biophys Acta. 2005. PMID: 16054019 Review.

6

Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.

Serose A, Prudhon B, Salmon A, Doyennette MA, Fiszman MY, Fromes Y. Serose A, et al. Basic Res Cardiol. 2005 Mar;100(2):161-70. doi: 10.1007/s00395-004-0506-3. Epub 2004 Dec 22. Basic Res Cardiol. 2005. PMID: 15611844

7

rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.

Li J, Dressman D, Tsao YP, Sakamoto A, Hoffman EP, Xiao X. Li J, et al. Gene Ther. 1999 Jan;6(1):74-82. doi: 10.1038/sj.gt.3300830. Gene Ther. 1999. PMID: 10341878

8

Gene therapy prevents disruption of dystrophin-related proteins in a model of hereditary dilated cardiomyopathy in hamsters.

Toyo-oka T, Kawada T, Xi H, Nakazawa M, Masui F, Hemmi C, Nakata J, Tezuka A, Iwasawa K, Urabe M, Monahan J, Ozawa K. Toyo-oka T, et al. Heart Lung Circ. 2002;11(3):174-81. doi: 10.1046/j.1444-2892.2002.00151.x. Heart Lung Circ. 2002. PMID: 16352094

9

[A new paradigm for the progression of advanced heart failure].

Kawada T, Nakazawa M, Toyo-oka T. Kawada T, et al. Nihon Yakurigaku Zasshi. 2004 Feb;123(2):55-62. doi: 10.1254/fpj.123.55. Nihon Yakurigaku Zasshi. 2004. PMID: 14745124 Review. Japanese.

10

Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex.

Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, Hanaoka F. Sakamoto A, et al. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13873-8. doi: 10.1073/pnas.94.25.13873. Proc Natl Acad Sci U S A. 1997. PMID: 9391120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year